186 related articles for article (PubMed ID: 36967764)
1. Progesterone exerts a neuroprotective action in a Parkinson's disease human cell model through membrane progesterone receptor α (mPRα/PAQR7).
Castelnovo LF; Thomas P
Front Endocrinol (Lausanne); 2023; 14():1125962. PubMed ID: 36967764
[TBL] [Abstract][Full Text] [Related]
2. Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway.
Zuo L; Li W; You S
Breast Cancer Res; 2010; 12(3):R34. PubMed ID: 20540763
[TBL] [Abstract][Full Text] [Related]
3. Membrane progesterone receptors (mPRs) mediate progestin induced antimorbidity in breast cancer cells and are expressed in human breast tumors.
Dressing GE; Alyea R; Pang Y; Thomas P
Horm Cancer; 2012 Jun; 3(3):101-12. PubMed ID: 22350867
[TBL] [Abstract][Full Text] [Related]
4. Membrane Progesterone Receptor α (mPRα/PAQR7) Promotes Survival and Neurite Outgrowth of Human Neuronal Cells by a Direct Action and Through Schwann Cell-like Stem Cells.
Castelnovo LF; Thomas P
J Mol Neurosci; 2022 Oct; 72(10):2067-2080. PubMed ID: 35974286
[TBL] [Abstract][Full Text] [Related]
5. Progesterone induces relaxation of human umbilical cord vascular smooth muscle cells through mPRα (PAQR7).
Pang Y; Thomas P
Mol Cell Endocrinol; 2018 Oct; 474():20-34. PubMed ID: 29428395
[TBL] [Abstract][Full Text] [Related]
6. Progesterone increases nitric oxide synthesis in human vascular endothelial cells through activation of membrane progesterone receptor-α.
Pang Y; Dong J; Thomas P
Am J Physiol Endocrinol Metab; 2015 May; 308(10):E899-911. PubMed ID: 25805192
[TBL] [Abstract][Full Text] [Related]
7. Involvement of sarco/endoplasmic reticulum Ca
Pang Y; Thomas P
Am J Physiol Endocrinol Metab; 2021 Mar; 320(3):E453-E466. PubMed ID: 33427050
[TBL] [Abstract][Full Text] [Related]
8. Role of mPRα (PAQR7) in progesterone-induced Ca2+ decrease in human vascular smooth muscle cells.
Pang Y; Thomas P
J Mol Endocrinol; 2019 Oct; 63(3):199-213. PubMed ID: 31416049
[TBL] [Abstract][Full Text] [Related]
9. Comparison between steroid binding to membrane progesterone receptor alpha (mPRalpha) and to nuclear progesterone receptor: correlation with physicochemical properties assessed by comparative molecular field analysis and identification of mPRalpha-specific agonists.
Kelder J; Azevedo R; Pang Y; de Vlieg J; Dong J; Thomas P
Steroids; 2010 Apr; 75(4-5):314-22. PubMed ID: 20096719
[TBL] [Abstract][Full Text] [Related]
10. Membrane Progesterone Receptors (mPRs/PAQRs) Differently Regulate Migration, Proliferation, and Differentiation in Rat Schwann Cells.
Castelnovo LF; Caffino L; Bonalume V; Fumagalli F; Thomas P; Magnaghi V
J Mol Neurosci; 2020 Mar; 70(3):433-448. PubMed ID: 31749125
[TBL] [Abstract][Full Text] [Related]
11. Participation of membrane progesterone receptor α in the inhibitory effect of progesterone on prolactin secretion.
Camilletti MA; Ferraris J; Abeledo-Machado A; Converse A; Faraoni EY; Pisera D; Gutierrez S; Thomas P; Díaz-Torga G
J Neuroendocrinol; 2018 Sep; 30(9):e12614. PubMed ID: 29869822
[TBL] [Abstract][Full Text] [Related]
12. Progestin signaling through mPRα in Atlantic croaker granulosa/theca cell cocultures and its involvement in progestin inhibition of apoptosis.
Dressing GE; Pang Y; Dong J; Thomas P
Endocrinology; 2010 Dec; 151(12):5916-26. PubMed ID: 20962051
[TBL] [Abstract][Full Text] [Related]
13. Expression of membrane progesterone receptors (mPR/PAQR) in ovarian cancer cells: implications for progesterone-induced signaling events.
Charles NJ; Thomas P; Lange CA
Horm Cancer; 2010 Aug; 1(4):167-76. PubMed ID: 21761364
[TBL] [Abstract][Full Text] [Related]
14. mPRα and PR co-operate in progesterone inhibition of endothelial cell focal adhesion.
Pang Y; Thomas P
J Mol Endocrinol; 2023 Jan; 70(1):. PubMed ID: 36099054
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of cell surface expression and receptor functions of membrane progestin receptor α (mPRα) by progesterone receptor membrane component 1 (PGRMC1): evidence for a role of PGRMC1 as an adaptor protein for steroid receptors.
Thomas P; Pang Y; Dong J
Endocrinology; 2014 Mar; 155(3):1107-19. PubMed ID: 24424068
[TBL] [Abstract][Full Text] [Related]
16. Orexin-A Protects Human Neuroblastoma SH-SY5Y Cells Against 6-Hydroxydopamine-Induced Neurotoxicity: Involvement of PKC and PI3K Signaling Pathways.
Pasban-Aliabadi H; Esmaeili-Mahani S; Abbasnejad M
Rejuvenation Res; 2017 Apr; 20(2):125-133. PubMed ID: 27814668
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the neuroprotective potential of caffeic acid phenethyl ester in a cellular model of Parkinson's disease.
Turan D; Abdik H; Sahin F; Avşar Abdik E
Eur J Pharmacol; 2020 Sep; 883():173342. PubMed ID: 32634439
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
[TBL] [Abstract][Full Text] [Related]
19. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.
Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL
Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565
[TBL] [Abstract][Full Text] [Related]
20. Progesterone signals through membrane progesterone receptors (mPRs) in MDA-MB-468 and mPR-transfected MDA-MB-231 breast cancer cells which lack full-length and N-terminally truncated isoforms of the nuclear progesterone receptor.
Pang Y; Thomas P
Steroids; 2011 Aug; 76(9):921-8. PubMed ID: 21291899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
